ÂÜÀòÂÒÂ×

Sara Secall is an experienced board member and partner with a robust background in the biotechnology sector. Current roles include board memberships at Ability Pharmaceuticals, AmacaThera, CONNECTA Therapeutics, OXOLIFE, AptaTargets, Oncostellae, and Innoup Pharma, where Sara contributes to the development of innovative therapies and nanotechnology platforms. Previously, Sara served as a board member at 53Biologics and Agrasys SL, focusing on bioprocessing and non-GMO crops, respectively. Educational credentials include an MBA from London Business School, a Master's in Environmental Science from Indiana University Bloomington, and a Bachelor of Science in Chemistry from Universitat de Barcelona.